Tech Gains Offset Rising Yields in a Divided Market Week

The trading week of September 21–25, 2026 concluded with the S&P 500 recording a modest move of +1.3%, leaving the benchmark -0.8% from its 52-week high. Volatility measures subsided slightly across the five trading sessions, as the VIX shifted from 14.8 following the opening day to 14.2 at Friday's close. Market breadth under the surface presented a divided picture: only 43.1% of S&P 500 constituents registered gains over the full week. On Friday, 7 S&P 500 stocks established new 52-week highs, while 13 touched new 52-week lows. Across all U.S. stocks graded by EasyAlpha, a population that includes small caps, 39.1% moved higher over the same five sessions. The week's verdict is that headline stability was maintained primarily by large technology shares, while higher bond yields applied pressure to the majority of individual equities.

The Week in Review

The week unfolded in two distinct phases, driven by shifting Treasury yields and energy prices. Trading began on a positive note on Monday, which delivered the week's strongest session with an S&P 500 return of +1.6%. Major benchmarks advanced on Monday as crude oil prices and bond yields eased, creating a favorable backdrop for semiconductor and software companies. That momentum carried into Tuesday, when major indexes held close to record territory after Brent crude dropped below $100 per barrel.

The market reversed course on Wednesday. U.S. stocks slid as stronger economic data and bond market pressure revived worries about inflation, with the 10-year Treasury yield climbing above 5.1%. Markets experienced continued friction on Thursday as Treasury yields approached 5.2% while energy prices rebounded. Equities stabilized on Friday as crude oil prices eased into the weekend, securing a positive weekly finish for large-cap indexes.

Index and Sector Performance

Performance across major market segments showed clear divergence based on market capitalization and sector exposure. The tech-heavy Nasdaq 100 outpaced the broader market, logging +3.3% over the five sessions. The Dow Jones Industrial Average posted a more subdued return of +0.3%. Small-cap equities lagged significantly, with the Russell 2000 proxy finishing -0.8%.

Sector performance reflected the same dynamic. Technology was the top-performing group, as its Select Sector SPDR fund generated +3.6%. Conversely, Utilities was the weakest sector, with its fund logging -3.1%.

Cross-Asset Moves and Dispersion

Fixed income markets saw notable selling pressure. The fund tracking long-dated U.S. Treasuries finished -2.4%, with the drop in fund price directly reflecting the sharp climb in long-term government bond yields. In digital assets, bitcoin moved +4.7% over the week.

Across S&P 500 stocks, cross-sectional dispersion registered at 4.6 points. This reading indicates an ordinary degree of return variation across individual members of the index, sitting within standard historical ranges. While index-level performance was driven by a concentrated group of tech leaders, individual stock outcomes did not diverge to an extreme level compared to typical weeks.

Company Highlights

Individual corporate news generated wide single-stock swings inside the S&P 500:

• Moderna Inc ranked as the top gainer in the index with a weekly move of +29.1%, after announcing that Phase 3 trial results for its mRNA melanoma therapy will be presented at an oncology symposium in October.
• Datadog Inc was the second-best performer in the index, closing +16.6%, though our sources show no reported driver or company-specific earnings announcements during the week.
• Gen Digital Inc. was the widest decliner in the S&P 500, ending -25.5% after news broke of an early-stage acquisition approach for GoDaddy, which drew analyst concerns regarding potential leverage and execution risk.
• MGM Resorts International was the second-largest decliner in the benchmark, recording -13.8% on the week.

Outside the index, smaller companies experienced wider price swings:

• GRAIL, LLC led all U.S. stocks graded by EasyAlpha with a weekly return of +57.1%, boosted after an FDA advisory panel voted to recommend approval for its Galleri multi-cancer early detection blood test following favorable regulatory review documents.
• Compass Therapeutics Inc. saw the steepest drop among all graded U.S. stocks, finishing -40.5% after announcing that FDA feedback requires an additional survival-benefit clinical trial for its cancer candidate before seeking regulatory approval.

Scheduled Events Next Week

Corporate earnings will pick up in the coming week. Across the S&P 500, 7 companies are scheduled to release quarterly financial results. The reporting lineup includes Micron Technology Inc, Accenture plc, Nike Inc, Jabil Circuit Inc.